Clinical Relevance of T1-S, an Oncogene-Inducible, Secreted Glycoprotein of the Immunoglobulin Superfamily, in Node-Negative Breast Cancer
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 81 (2) , 159-165
- https://doi.org/10.1038/labinvest.3780223
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector functionProceedings of the National Academy of Sciences, 1998
- Recent advances in breast cancer biologyCurrent Opinion in Oncology, 1997
- Expression of ST2, an Interleukin-1 Receptor Homologue, Is Induced by Proinflammatory StimuliBiochemical and Biophysical Research Communications, 1997
- Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancerBritish Journal of Cancer, 1997
- Recent advances in breast cancer biologyCurrent Opinion in Oncology, 1995
- Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S‐phase fraction and that of the antibodies to Ki‐67 and PCNA antigens detected by immunocytochemistryInternational Journal of Cancer, 1994
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Prognostic Factors in Breast CancerHematology/Oncology Clinics of North America, 1989
- Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen.Proceedings of the National Academy of Sciences, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958